Pfizer UK appoints new MD
This article was originally published in Scrip
Erik Nordkamp has been appointed managing director and head of Global Innovative Pharmaceutical business at Pfizer UK, taking over from Jonathan Emms who has been appointed global marketing lead for Pfizer's Global Established Pharmaceutical business. Mr Nordkamp joined Pfizer in 2010 and for the past year has led the firm's Greece, Cyprus and Malta, and the Global Innovative Pharmaceutical business. Prior to this, he worked for Pfizer in the UK as head of strategy for Primary Care Europe and Canada. Erik also served as president of PhRMA Innovation, a trade association, where he led the transformation of the forum, positioning it as the main representative body for the innovative pharmaceutical industry in Greece.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.